SpringWorks Therapeutics Inc.

Summer is the time for sequels at the multiplex, and the biopharmaceutical sector offered a remake of its own as many of the datapoints for merger-and-acquisition activity during the second quarter ca

Thirteen medicines were backed for pan-EU marketing authorizations this week by the European Medicines Agency’s human medicines committee, the CHMP, including Madrigal Pharmaceuticals’ Rezdiffra (resm

The European Medicines Agency’s human medicines committee, the CHMP, is expected to decide this week whether to recommend pan-EU marketing authorization for 12 new medicines, including Madrigal Pharma

Four drugs with an orphan designation – Aucatzyl (obecabtagene autoleucel), Blenrep (belantamab mafodotin), Ezmekly (mirdametinib) and Maapliv (amino acids) – are among the 10 new products on track fo